Precision Instruments · Fiscal year end Mar 31

MEDIKIT CO.,LTD

7749

メディキット株式会社

FIGI BBG000BZ1JS67749.T7749 JPCorp. no. 9010001007828

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-13

For the first half of the fiscal year to 2026-03: Revenue ¥11.9 billion (+5.6% YoY), Ordinary income ¥2.3 billion (+2.4% YoY), Net income ¥1.4 billion (+5.6% YoY).

	This period	Year on year
Revenue	¥11.9bn	+5.6%
Ordinary profit	¥2.3bn	+2.4%
Net profit to owners	¥1.4bn	+5.6%

From the securities report on EDINET, which states no forecast. History via /v1/companies/7749/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2026-03-31

Revenue: ¥23.8bn
Net income: ¥3.0bn
ROE: 6.5%
Equity ratio: 87.8%
Dividend / share: ¥100
Employees: 994

Revenue · ¥bn

Net income · ¥bn

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2026-03-31	¥23.8bn	¥3.0bn	¥53.3bn	¥46.8bn	6.5%	¥206.37	¥4.7bn
2025-03-31	¥22.6bn	¥3.0bn	¥52.5bn	¥45.2bn	6.8%	¥204.55	¥3.6bn
2024-03-31	¥21.9bn	¥3.1bn	¥51.0bn	¥44.1bn	6.7%	¥187.95	¥4.8bn
2023-03-31	¥21.6bn	¥2.9bn	¥53.2bn	¥47.3bn	6.2%	¥170.67	¥4.5bn
2022-03-31	¥20.1bn	¥3.0bn	¥51.1bn	¥45.8bn	6.7%	¥178.14	¥3.2bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31

Metric	Value	Percentile among listed companies
ROE, %	6.5	35.5
Ordinary margin	0.1886	88.9
Equity ratio, %	87.8	97.1
Revenue growth	0.0545	52.6
Net income growth	-0.0025	35.2
Operating cash flow / assets	0.0889	66.9

Policy-uncertainty measure0.84 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Trade & tariffs 1 Regulation 1 Politics & geopolitics 1

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 1 new 5% holder(s) in 180 days; net stake change +0.36pt in 90 days; 0.3% held by other listed companies.

Results wording balance: 0.00. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/7749/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Share buyback, report to —: ¥410m acquired of a ¥410m limit. /v1/companies/7749/buybacks

Internal control, 2026-06-24: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断した。 Filing

Segments, votes and tender offers

Stated in EDINET filings

Latest voting result: 2026-06-25 · 剰余金処分の件 · passed. /v1/companies/7749/voting

Latest tender-offer filing: 2024-01-10 · result · メディキット株式会社. /v1/companies/7749/tender-offers

Ownership changes

All companies →

2026-09-11

Increase+0.36pt

VARECS Partners Limited raised holdings in MEDIKIT CO.,LTD (7749) to 14.53% from 14.17%.

S100Z0XEFiler profile Original filing (PDF, Japanese)
2026-07-23

Decrease−0.33pt

FIAM LLC reduced holdings in MEDIKIT CO.,LTD (7749) to 6.15% from 6.48%.

S100YRDGFiler profile Original filing (PDF, Japanese)
2026-06-10

Amendment+1.43pt

FMR LLC filed a correction to a 5% report on MEDIKIT CO.,LTD (7749).

S100Y9HRFiler profile Original filing (PDF, Japanese)
2026-06-10

Increase+1.43pt

Fidelity Management & Research Company LLC raised holdings in MEDIKIT CO.,LTD (7749) to 6.48% from 5.05%.

S100Y9YYFiler profile Original filing (PDF, Japanese)
2026-06-09

Amendment−1.43pt

FMR LLC filed a correction to a 5% report on MEDIKIT CO.,LTD (7749).

S100Y97IFiler profile Original filing (PDF, Japanese)
2026-06-09

New 5% stake

Fidelity Management & Research Company LLC disclosed a 5.05% stake in MEDIKIT CO.,LTD (7749), crossing the 5% reporting threshold.

S100Y9BZFiler profile Original filing (PDF, Japanese)
2025-08-26

Increase+0.02pt

individual filer raised holdings in MEDIKIT CO.,LTD (7749) to 40.67% from 40.65%.

S100WJUSOriginal filing (PDF, Japanese)
2025-07-22

Increase+6.07pt

individual filer raised holdings in MEDIKIT CO.,LTD (7749) to 40.65% from 34.58%.

S100WD4XOriginal filing (PDF, Japanese)
2025-03-07

Increase+1.47pt

VARECS Partners Limited raised holdings in MEDIKIT CO.,LTD (7749) to 14.17% from 12.70%.

S100VC2CFiler profile Original filing (PDF, Japanese)
2025-03-07

Increase+1.43pt

FMR LLC raised holdings in MEDIKIT CO.,LTD (7749) to 6.48% from 5.05%.

S100VCNPFiler profile Original filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports

Bought SoldHover a dot for the trade

Holder	Period	Net shares	Net % of shares	Avg. filed price	Range
individual filer	2024-05-15 – 2025-08-20	-545,100	−3.44pt	¥2,514.79	¥2,513–2,948
individual filer	2023-05-23 – 2025-08-20	-420,500	−1.67pt	¥2,422.15	¥2,388–2,513
株式会社ヴァレックス・パートナーズ	2023-11-14 – 2025-02-28	+97,100	+0.47pt	—	—
individual filer	2024-05-15 – 2024-05-15	0	0.00pt	—	—
ユナイテッド・マネージャーズ・ジャパン株式会社	2023-11-15 – 2023-12-29	+2,800	0.00pt	—	—
individual filer	2023-05-23 – 2023-05-23	-1,030,000	−5.46pt	¥2,440	¥2,440–2,440

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/7749/trades.

5% filings

Large shareholding reports on 7749

Filed	Filer	Stake	Change	Stated purpose
2026-09-11	VARECS Partners Limited	14.53%	+0.36pt	may make proposals pure investment
2026-07-23	FIAM LLC	6.15%	−0.33pt	—
2026-06-10	FMR LLC	6.48%	+1.43pt	—
2026-06-10	Fidelity Management & Research Company LLC	6.48%	+1.43pt	—
2026-06-09	FMR LLC	5.05%	—	—
2026-06-09	Fidelity Management & Research Company LLC	5.05%	—	—
2025-08-26	individual filer	40.67%	+0.02pt	management participation
2025-07-22	individual filer	40.65%	+6.07pt	management participation
2025-03-07	VARECS Partners Limited	14.17%	+1.47pt	may make proposals pure investment
2025-03-07	FMR LLC	6.48%	+1.43pt	—

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: — issues
Book value: —
Sold in the year: — — issues
Bought in the year: — — issues
Mutual, both reports: 0
Held by listed cos.: 1

Held by: The Miyazaki Bank,Ltd. 8393

Purposes, all holdings and mutual flags via /v1/companies/7749/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31

Shareholder	Shares	Ratio
㈱ナカジマコーポレーション	5,890,500	40.69%
individual holder	1,401,480	9.68%
individual holder	900,600	6.22%
individual holder	892,300	6.16%
一般財団法人中島育英奨学会	600,000	4.14%
individual holder	567,400	3.92%
individual holder	476,300	3.29%
individual holder	475,000	3.28%
individual holder	446,306	3.08%
メディキット社員持株会	188,622	1.30%

U.S. funds holding 7749

SEC Form N-PORT, reports to 2026-07-31

11 U.S. funds held 920,219 shares worth $16.2m.

Fund	Shares	Value	% of fund	As of
Fidelity Series International Small Cap Fund Fidelity Investment Trust	606,400	$10.7m	0.413%	2026-07-31
Fidelity International Small Cap Opportunities Fund Fidelity Investment Trust	291,800	$5.1m	0.312%	2026-07-31
Fidelity Total International Equity Fund Fidelity Investment Trust	12,019	$0.2m	0.009%	2026-07-31
INTERNATIONAL CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC	3,300	$0.1m	0.000%	2026-07-31
International Vector Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC	2,800	$0.0m	0.001%	2026-07-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/7749
GET /v1/companies/7749/financials
GET /v1/companies/7749/details
GET /v1/companies/7749/segments
GET /v1/companies/7749/voting
GET /v1/companies/7749/tender-offers
GET /v1/companies/7749/indicators
GET /v1/companies/7749/earnings-releases
GET /v1/events?ticker=7749
GET /v1/companies/7749/trades         
GET /v1/companies/7749/cross-holdings 
GET /v1/companies/7749/brief

Plans from $9 a month · Documentation